Skip to content
Connect Career

Reader

EnVision® 2105 Multimode Plate Reader

The EnVision® 2105 Multimode Plate Reader is a versatile and sensitive instrument used in our laboratory for a variety of measurements. It is capable of detecting multiple applications, including absorbance, luminescence, and fluorescence. This multi-mode functionality allows us to perform complex assays with high sensitivity and a wide dynamic range, making it possible to detect both strong and weak signals on the same plate. This ensures accurate and reliable results from each well, giving us confidence in the data we collect.

Our lab utilizes the EnVision® 2105 Reader for several critical applications, including for example the Complement-Dependent Cytotoxicity (CDC) or the Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) assays. These assays are essential for evaluating the effectiveness of antibodies and other therapeutic agents, allowing us to measure their ability to induce cytotoxic responses in target cells.

In addition, the EnVision® 2105 is part of our drug screening processes to ensure that we can identify potential therapeutic candidates with precision and efficiency. The data obtained from these screenings is then further processed and analyzed. With its robust performance and versatile capabilities, the EnVision® 2105 Multimode Plate Reader is an indispensable tool in our laboratory to achieve high readout performance.

Reader

EnVision® 2105 Multimode Plate Reader

The EnVision® 2105 Multimode Plate Reader is a versatile and sensitive instrument used in our laboratory for a variety of measurements. It is capable of detecting multiple applications, including absorbance, luminescence, and fluorescence. This multi-mode functionality allows us to perform complex assays with high sensitivity and a wide dynamic range, making it possible to detect both strong and weak signals on the same plate. This ensures accurate and reliable results from each well, giving us confidence in the data we collect.

Our lab utilizes the EnVision® 2105 Reader for several critical applications, including for example the Complement-Dependent Cytotoxicity (CDC) or the Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) assays. These assays are essential for evaluating the effectiveness of antibodies and other therapeutic agents, allowing us to measure their ability to induce cytotoxic responses in target cells.

In addition, the EnVision® 2105 is part of our drug screening processes to ensure that we can identify potential therapeutic candidates with precision and efficiency. The data obtained from these screenings is then further processed and analyzed. With its robust performance and versatile capabilities, the EnVision® 2105 Multimode Plate Reader is an indispensable tool in our laboratory to achieve high readout performance.